CompuGroup Medical SE & Co. KGaA (CMPVF)
USD 23.85
(0.02%)
USD 23.85
(0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 198.15 Million | 155.21 Million | 187.85 Million | 183.44 Million | 124.03 Million | 155.86 Million |
| Net Income | 50.67 Million | 78.56 Million | 78.39 Million | 89.55 Million | 73.88 Million | 109.83 Million |
| Depreciation & Amortization | 127.81 Million | 120.21 Million | 125.84 Million | 92.5 Million | 69.15 Million | 47.7 Million |
| Deferred income taxes | -16.88 Million | 376.72 Thousand | -5.3 Million | 7.68 Million | 12 Million | -5.79 Million |
| Stock-based compensation | -7.76 Million | 2.83 Million | 6.5 Million | 7.18 Million | 4.37 Million | - |
| Change in working capital | -10.03 Million | -46.2 Million | 4.97 Million | -14.81 Million | -27.02 Million | -17.39 Million |
| Other non-cash items | -207.98 Million | -238.91 Million | -267.8 Million | -176.77 Million | 140.6 Million | 138.14 Million |
| Investing Cash Flow | -142 Million | -155.64 Million | -186.39 Million | -559.79 Million | -158.04 Million | -54.31 Million |
| Investments in PPE | -74.89 Million | -81.77 Million | -81.2 Million | -68.18 Million | -49.09 Million | -46.12 Million |
| Acquisitions | -41.89 Million | -61.54 Million | -91.88 Million | -485.29 Million | -106.98 Million | -4.69 Million |
| Investment purchases | -8.34 Million | -4.95 Million | -6.88 Million | -2.48 Million | - | - |
| Sales/Maturities of investments | - | -2.00 | - | - | - | - |
| Other Investing Activities | -16.87 Million | -7.37 Million | -6.42 Million | -3.83 Million | -1.96 Million | -3.48 Million |
| Financing Cash Flow | -84.27 Million | -17.49 Million | 34.28 Million | 414.13 Million | 57.28 Million | -106.74 Million |
| Debt repayment | -26.72 Million | -47.72 Million | -197.7 Million | -50.91 Million | -132.36 Million | -58.19 Million |
| Dividends payments | -28.82 Million | -27.95 Million | -29.96 Million | -29.61 Million | -27.4 Million | -19.89 Million |
| Common Stock Repurchased | - | -9.74 Million | -109.22 Million | -20.5 Million | -46.09 Million | -28.54 Million |
| Common Stock Issuance | - | -27.32 Million | -24.03 Million | 413.54 Million | - | - |
| Other Financing Activities | -232.88 Thousand | 95.25 Million | 395.21 Million | 101.63 Million | -1.58 Million | -117.74 Thousand |
| Accounts receivables | 24.24 Million | -49.85 Million | -24.67 Million | -41.89 Million | -3.88 Million | -7.76 Million |
| Accounts payables | -23.26 Million | 16.65 Million | 27.17 Million | 13.77 Million | 4.59 Million | -5.37 Million |
| Inventory | 11.67 Million | -9.4 Million | -2.59 Million | 11.61 Million | -7 Million | -8.08 Million |
| Other working capital | -22.69 Million | -3.6 Million | 5.06 Million | 1.68 Million | -20.73 Million | 3.82 Million |
| Cash at beginning of period | 96.87 Million | 122.01 Million | 92.87 Million | 52.02 Million | 28.92 Million | 36.45 Million |
| Cash at end of period | 71.14 Million | 96.87 Million | 122.01 Million | 92.87 Million | 52.02 Million | 28.92 Million |
| Capital Expenditure | -74.89 Million | -81.77 Million | -81.2 Million | -68.18 Million | -49.09 Million | -46.12 Million |
| Effect of forex changes on cash | -570 Thousand | -80 Thousand | -18 Thousand | -1.32 Million | -0.47 | - |
| Net cash flow / Change in cash | -25.72 Million | -25.13 Million | 29.13 Million | 40.85 Million | 23.1 Million | -7.53 Million |
| Free Cash Flow | 123.26 Million | 73.44 Million | 106.65 Million | 115.26 Million | 74.93 Million | 109.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 14.91 Million | 19.98 Million | 50.67 Million | -17.55 Million | 16.85 Million | 34.34 Million |
| Depreciation & Amortization | 30.47 Million | 28.6 Million | 127.81 Million | 40.42 Million | 28.28 Million | 28.46 Million |
| Deferred income taxes | -2.9 Million | 701.35 Thousand | -16.88 Million | -16.89 Million | 21.14 Thousand | 19.63 Thousand |
| Stock-based compensation | 372.79 Thousand | 375.52 Thousand | -7.76 Million | 353.27 Thousand | -1.07 Million | -7.57 Million |
| Change in working capital | -17.79 Million | 58.7 Million | -10.03 Million | -12.99 Million | -22.04 Million | -35.51 Million |
| Other non-cash items | -3.15 Million | 77.03 Million | -207.98 Million | -24.4 Million | -57.5 Million | -63.85 Million |
| Investing Cash Flow | -56.99 Million | -19.08 Million | -142 Million | -35.6 Million | -21.13 Million | -38.09 Million |
| Investments in PPE | -16.58 Million | -21.02 Million | -74.89 Million | -23.84 Million | -14.92 Million | -15.64 Million |
| Acquisitions | -39.02 Million | 2.96 Million | -41.89 Million | -742.81 Thousand | -6.02 Million | -10.78 Million |
| Investment purchases | - | -337.72 Thousand | -8.34 Million | -8.14 Million | -190.27 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.38 Million | -683 Thousand | -16.87 Million | -2.86 Million | -1.00 | -11.66 Million |
| Financing Cash Flow | 18.73 Million | -7.48 Million | -84.27 Million | -15.09 Million | 6.73 Million | 10.47 Million |
| Debt repayment | -96.16 Million | -6.77 Million | -26.72 Million | -7.44 Million | -13.92 Million | -45.54 Million |
| Dividends payments | -55.41 Million | - | -28.82 Million | - | - | -28.48 Million |
| Common Stock Repurchased | -14.98 Million | -705.66 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.00 | - | -232.88 Thousand | 4.54 Million | 20.66 Million | 84.51 Million |
| Accounts receivables | 57 Million | -44.33 Million | 24.24 Million | 1.97 Million | 2.76 Million | 12.93 Million |
| Accounts payables | -22.24 Million | -717.53 Thousand | -23.26 Million | 15.1 Million | 2.36 Million | -2.82 Million |
| Inventory | -1.24 Million | 2.29 Million | 11.67 Million | 2.57 Million | 949.26 Thousand | 2.01 Million |
| Other working capital | -51.31 Million | 101.47 Million | -22.69 Million | -32.65 Million | -28.12 Million | -47.64 Million |
| Cash at beginning of period | 127.48 Million | 71.14 Million | 96.87 Million | 70.38 Million | 63.31 Million | 71.1 Million |
| Cash at end of period | 83.28 Million | 127.48 Million | 71.14 Million | 71.14 Million | 70.38 Million | 63.31 Million |
| Capital Expenditure | -16.58 Million | -21.02 Million | -74.89 Million | -23.84 Million | -14.92 Million | -15.64 Million |
| Effect of forex changes on cash | 844 Thousand | -520 Thousand | -570 Thousand | 503 Thousand | 361 Thousand | -547 Thousand |
| Net cash flow / Change in cash | -44.19 Million | 56.33 Million | -25.72 Million | 760.79 Thousand | 7.07 Million | -7.79 Million |
| Free Cash Flow | -22.48 Million | 64.03 Million | 123.26 Million | 23.95 Million | 8.12 Million | 4.31 Million |
1725
6370
4502
9101
009320
AVN